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Nesfatin-1, processed from nucleobindin 2, is an anorexigenic peptide expressed 
in the brain and several peripheral tissues including the stomach and pancreas. 
Peripheral, as well as intracerebroventricular, administration of nesfatin-1 
suppresses feeding behavior, though underlying mechanisms are unknown. In this 
study, we examined effects of nesfatin-1 on cytosolic Ca2+ concentration 
([Ca2+] i) in the neurons isolated from the vagal afferent nodose ganglion of mice. 
Nesfatin-1 at 10-10 to 10-8 M increased [Ca2+] i  in the isolated neurons in a 
concentration-dependent manner, and at 10-8 M it increased [Ca2+] i  in 33 out of 
263 (12.5%) neurons. These responses were inhibited under Ca2+-free conditions 
and by N-type Ca2+ channel blocker, ω-conotoxin GVIA. All the 
nesfatin-1-responsive neurons also exhibited [Ca2+]i  responses to capsaicin and 
cholecystokinin-8. These results provide direct evidence that nesfatin-1 activates 
vagal afferent neurons by stimulating Ca2+ influx through N-type channels, 
demonstrating the machinery through which peripheral nesfatin-1 can convey 
signals to the brain. 
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Nesfatin-1 is a recently discovered anorexigenic peptide encoded in the 
precursor protein, nucleobindin 2 (NUCB2) [1]. Nesfatin-1/NUCB2 is localized 
in the hypothalamic paraventricular nucleus (PVN), arcuate nucleus (ARC), 
supraoptic nucleus (SON) and lateral hypothalamic area (LHA) [1], and in the 
brainstem nucleus of the solitary tract (NTS) and dorsal motor nucleus of the 
vagus (DMV) [1, 2], which are the feeding-related areas.  
Intracerebroventricular (icv) administration of nesfatin-1 suppresses food intake, 
whereas icv administration of nesfatin-1 antibody increases food intake [1]. 
Interestingly, nesfatin-1 also inhibits food intake in Zucker fatty rats whose leptin 
receptor is mutated [1], indicating that the anorexigenic effect of nesfatin-1 is 
leptin-independent. 
Recently, nesfatin-1 immunoreactivity was also found in the peripheral 
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tissues including stomach [3] and pancreatic islets [4]. Peripheral administration 
of nesfatin-1 reduces food intake in normal and leptin-resistant mice such as 
db/db and high-fat diet-induced obese mice [5]. Since nesfatin-1 can cross 
blood-brain barrier, nesfatin-1 injected peripherally might directly act on the 
neurons in the feeding-controlling centers to reduce food intake. On the other 
hand, there is the possibility that the anorexia induced by peripheral nesfatin-1 is 
via the afferent nervous system. In fact, peripheral administration of nesfatin-1 
induces expression of c-Fos in the NTS, which receives projections of vagal 
afferent nerves [5]. 
In this study, to investigate the effect of nesfatin-1 on the vagal afferent 
nerve, we monitored the activity of neurons isolated from the mouse nodose 
ganglion by measuring cytosolic Ca2+ concentration ([Ca2+] i) and investigated 
direct effects of nesfatin-1. Cholecystokinin (CCK)-8 is the well established 
peripheral peptide that acts on the vagal afferent nerve to produce anorexia [6]. 
Capsaicin (CAP) is also known to activate vagal afferent nerves [7]. Therefore, 
we examined whether the nodose ganglion neuron that responds to nesfatin-1 is 
distinct from or overlapping with the CCK-8- or CAP-responsive neuron.   
 
Materials and methods 
Materials 
Mouse nesfatin-1 was synthesized as previously reported [5]. CCK-8 
(sulfated form) was purchased from Peptide Institute, Inc. (Osaka, Japan). CAP 
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was obtained from Sigma (MO, USA) 
 
Animals 
Male ICR mice (Japan SLC, Shizuoka, Japan) aged 6 to 13 weeks were 
housed for at least 1 week under conditions of controlled temperature (23 ± 1°C), 
humidity (55% ± 5%), and lighting (light on at 07:30 and off at 19:30). Food and 
water were available ad libitum. Procedures of animal experiments were approved 
by the Animal Care and Use Committee of the Jichi Medical University. 
 
Preparation of nodose ganglion neurons from mice 
Single neurons were isolated from mouse nodose gangalia, according to the 
methods reported by Simasko et al. with minor modifications [8]. Briefly, male 
ICR mice were anesthetized with a-chloralose and urethane (0.1 g/kg and 1 g/kg, 
i.p., respectively), and nodose ganglia were excised. These ganglia were rapidly 
cut into 4 or 5 pieces in ice-cold HEPES-buffered Krebs-Ringer bicarbonate 
buffer (HKRB) composed of 4.7 mM KCl, 1.2 mM KH2PO4, 129 mM NaCl, 5 
mM KaHCO3, 1.2 mM MgSO4, 1.8 mM CaCl2, and 10 mM HEPES with pH 
adjusted at 7.4 using NaOH supplemented with 5.6 mM glucose, The tissue pieces 
were dissociated by incubation for 20 minutes at 37 °C in the HKRB containing 
0.7 mg/ml collagenase Ia (Sigma), 0.7 mg/ml dispase II (Roche, Basel, Swiss), 15 
µg/ml DNase II type IV (Sigma), and 0.75 mg/ml bovin serum albumin. Cells 
were gently triturated using fire-polished pasteur pipettes and centrifugated 2 
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times in Eagle’s minimal essential medium (MEM) containing 5.6 mM glucose 
supplemented with 10% feral bovine serum, 100 µg/ml streptomycin, and 100 
units/ml penicillin. Cells were resuspended in MEM and plated onto coverslips 
coated with poly-L-lysin. Cells were cultured in MEM for 18-36 h.  
 
Measurements of [Ca2+] i
Measurements of [Ca2+] i  in primary cultured nodose ganglion neurons were 
carried out according to the procedures reported previously [9]. Briefly, 
following incubating with 2 µM fura-2 AM (DOJINDO, Kumamoto, Japan) for 30 
min at 37 °C, the cells were mounted in a chamber and superfused with HKRB at 
1.3 ml/min at 30 °C. Fluorescence images at 510 nm due to excitation at 340 and 
380 nm were detected every 10 s with an intensified charge-coupled device 
camera, and ratio images were produced by an Aquacosmos ver. 2.5 (Hamamatsu 
Photonics, Shizuoka, Japan). When [Ca2+]i  changed within 5 min after addition of 
agents and their amplitudes were at least twice larger than the fluctuations of the 
baseline, they were considered responses. Only the cells that responded to 55 mM 
KCl were analyzed. 
 
Data analysis 
Statistical analysis was performed by one-way ANOVA and Tukey’s 
multiple comparison tests for multiple groups, and by unpaired t-test for two 
groups. All data were shown as means ± SEM. P<0.05 was considered significant. 
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 Results 
Nesfatin-1 increased [Ca2+]i in mouse nodose ganlion neurons 
To evaluate directly effect of nesfatin-1 on vagal afferent nerve, we 
measured [Ca2+] i  changes in fura-2 loaded nodose ganlion neurons before and 
after treatment of nesfatin-1. Administration of nesfatin-1 at 10-8 M for 15 min 
increased [Ca2+] i  in nodose ganglion neurons as shown in Fig. 1A. The [Ca2+] i  
returned to the basal level after washing out nesfatin-1. To confirm 
concentration-dependency, as shown in Fig. 1B nesfatin-1 at 10-10, 10-9  and 10-8  
M were sequentially applied to nodose ganglion neurons with treatment and 
washing periods for 4 and 8 min, respectively. Nesfatin-1 at 10-10, 10-9 and 10-8  
M raised [Ca2+] i in 10 of 119 (8.4%), 15 of 119 (12.6%) and 18 of 119 (15.1%) 
neurons examined, respectively (Fig. 1C). Thus, incidence of 
nesfatin-1-responsive neurons increased in a concentration-dependent manner. 
Moreover, in these 18 nesfatin-1-responsive neurons, amplitudes of [Ca2+] i  
responses to nesfatin-1 also increased in a concentration-dependent manner (Fig. 
1D). 
 
Inhibition of nesfatin-1-induced [Ca2+] i increases under Ca2+-free condition and 
by N-type Ca2+ channel blocker   
Involvement of extracellular Ca2+ in nesfatin-1-induced [Ca2+]i  increases in 
nodose ganlion neurons was examined. In a Ca2+-free condition made with no 
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added Ca2+ and 0.1 mM EGTA, nesfatin-1 at 10-8 M failed to increase [Ca2+] i  in 
all the cells examined. After bringing Ca2+ back to HKRB that often elevated 
[Ca2+] i  in a transient manner, nesfatin-1 elicited [Ca2+] i  increases in 14 of 100 
neurons (14.0%) (Figs. 2A and 2C). 
The effect of ω-conotoxin GIVA, a blocker of voltage-gated N-type Ca2+ 
channels, on nesfatin-1-induced [Ca2+] i responses was examined with the 
protocol shown in Fig. 2B. In the presence of ω-conotoxin GVIA (0.5 µM), 
administration of 10-8 M nesfatin-1 induced either no change or small increase in 
[Ca2+] i , and after washing out the agents, second stimulation with nesfatin-1 
(10-8 M) raised robust increases in [Ca2+] i  (Fig. 2B). Amplitude of [Ca2+] i  
responses to 10-8 M nesfatin-1 was significantly smaller in the presence than the 
absence of ω-conotoxin GVIA (0.5 µM) (Fig. 2C). Furthermore, ω-conotoxin 
GIVA at 0.1 µM also attenuated the nesfatin-1-induced [Ca2+] i  increase, though 
to a lesser extent than at 0.5 µM (Fig. 2C), showing a dose-dependent blocking 
effect. 
  
Relationship between nesfatin-1-responsive neurons and CCK-8- or 
CAP-responsive neurons 
We examined whether nesfatin-1-responsive neurons are distinct from or 
overlap with CCK-8- or CAP-responsive neurons in the nodose ganglion.  
Nodose ganglion neurons were exposed sequentially to nesfatin-1 (10-8 M), 
CCK-8 (10-8 M), CAP (10-7 M), and KCl (55 mM) (Fig. 3A). Nesfatin-1, CCK-8, 
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and CAP evoked [Ca2+] i  increases in 33 (12.5%), 132 (50.2%), and 164 (62.4%) 
of 263 neurons that responded to KCl, respectively (Fig. 3B). Furthermore, all of 
33 neurons that responded to nesfatin-1 with [Ca2+] i  increases also responded to 
both CCK-8 and CAP (Fig. 3C).  
 
Discussion  
This study demonstrated that nesfatin-1 directly interacts with nodose 
ganglion neuron and increases [Ca2+] i  by stimulating Ca2+ influx primarily 
through voltage-gated N-type Ca2+ channels, and that the nesfatin-1-responsive 
neurons occur in a portion of CAP- and CCK-8-responsive neurons.  
The [Ca2+] i  responses to nesfatin-1 were markedly inhibited by ω-conotoxin 
GIVA, an N-type Ca2+ channel blocker. It has been reported that 10-7 M 
nesfatin-1-induced [Ca2+] i  increases in the hypothalamic single neurons were 
linked to L-type and P/Q-type Ca2+ channels [2]. These results by us and others 
suggest that the mechanisms by which nesfatin-1 increases [Ca2+] i  are different 
between the central neurons and the nodose ganglion neurons. The dominant role 
of the N-type Ca2+ channel in the nesfatin-1-induced [Ca2+] i  increases in the 
nodose ganglion neurons is apparently in accordance with the documents that this 
channel type is implicated in the regulation of the autonomic nerve activity [7]. 
In this study, the concentrations at which nesfatin-1 increased [Ca2+] i  in 
mouse nodose ganglion neurons were 10-10 M to 10-8 M. It was reported that 
serum concentration of nesfatin-1 in the humans fasted overnight is around 0.2 
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ng/ml (0.2×10-10 M). In our preliminary study, the plasma concentration of 
nesfatin-1 before breakfast in healthy humans is in a range of 1 to 10 ng/ml (10-10  
to 10-9 M) (unpublished data). On the other hand, expressions of NUCB2 in the 
PVN [1] and gastric mucosa [3] are lower under fasting than ad libitum 
conditions, suggesting that the nesfatin-1 level in the circulation may be elevated 
by food intake. Furthermore, the nesfatin-1 level in the vicinity of 
nesfatin-1-producing tissues such as stomach and pancreas could be higher than 
that in the circulation. Collectively, it is suggested that, the effective 
concentration of nesfatin-1 to activate nodose ganglion neurons, 10-10 M, 
observed in this study, could be achieved at the site of vagal afferent fibers under 
in situ physiological concentrations and that nodose ganglion neurons are 
possibly activated by endogenous nesfatin-1. 
The middle-segment of nesfatin-1 composed of 30 amino acids, M30, is as 
potent as nesfatin-1 in inducing anorexia, while the former- and post-segments 
were ineffective on food intake [5]. Both M30 and nesfatin-1 inhibit food intake 
when administered peripherally as well as centrally [1, 5]. However, in mice 
pretreated with CAP, a procedure to deplete CAP-sensitive afferent nerves, 
peripheral administration of M30 fails to show anorexigenic action [10]. These 
results have suggested that induction of anorexia by nesfatin-1 and its active 
segment M30 is, at least in part, due to activation of CAP-sensitive afferent 
nerves. The present study demonstrated that nesfatin-1 directly activates 
CAP-responsive nodose ganglia neurons of the vagal afferent. 
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CCK is one of the anorexigenic peptides secreted from enteroendocrine I 
cells after meal intake. It has been demonstrated that CCK exerts its anorexigenic 
effect via acting on the vagal afferent nerves [11]. We found that CCK-8 increases 
[Ca2+] i  in 50.2% of mouse nodose ganglion neurons, confirming the previous 
document in rat nodose ganglion neurons [12]. Moreover, in the present study, 
nesfatin-1 increased [Ca2+] i  exclusively in the neurons that responded to CCK-8. 
Our data indicate that the nesfatin-1-responsive neurons occupy a portion of 
CCK-8-responsive neurons, and suggest that nesfatin-1 and CCK-8 share the 
same target neurons of nodose ganglia that could be linked to inhibition of 
feeding. Conversely, it has been reported that peripheral administration of CCK 
stimulates c-Fos expression in nesfatin-1-containing neurons in the hypothalamic 
PVN and brain stem NTS [13]. These data by us and others, taken together,, raise 
the possibility that peripheral and central nesfatin-1 could have a strong 
connection with the neurons that respond to peripheral CCK with respect to the 
regulation of food intake. 
 
Conclusions 
This study revealed that nesfatin-1 induces Ca2+ signaling in the vagal 
nodose ganglion neurons, and that the nesfatin-1-responsive neurons occur in the 
CAP- and CCK-8-responsive neurons. The results suggest that nesfatin-1 
activates the nodose ganglion neurons that are implicated in feeding. Our study, 
by revealing a key cellular process, substantiated the hypothesis that peripheral 
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nesfatin-1 signals to the brain via interacting with the afferent vagus nerves [5, 
10]. This interaction could underlie the anorexigenic action of 
peripherally-produced nesfatin-1 under physiological conditions and serve as the 
therapeutic sensor of exogenous nesfatin-1 for treating patients with hyperphagic 
obesity.   
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Figure 1. Nesfatin-1 increases [Ca2+] i  in mouse nodose ganglion neurons. 
A: Administration of 10-8 M nesfatin-1 (Nesf-1) induced a continuous increase in 
[Ca2+] i  in a single nodose ganglion neuron that subsequently responded to 55 mM 
KCl. B: Repetitive administration of increasing concentrations of Nesf-1 at 10-10, 
10-9 and 10-8 M induced repeated [Ca2+] i  increases in a concentration-dependent 
manner in a single nodose ganglion neuron that responded to CAP and 55 mM 
KCl. In (A) and (B), [Ca2+] i  is expressed by fura-2 ratio and bars above the 
tracings indicate the periods of administration of agents specified. The data are 
representative of 22 neurons in (A) and 18 neurons in (B). C and D: 
Concentration-dependent effects of Nesf-1 to increase [Ca2+] i  in single nodose 
ganglion neurons examined by the protocol indicated in (B). Incidence of [Ca2+] i  
responses expressed by the percentage of neurons that responded to Nesf-1 (C), 
and amplitude of [Ca2+] i  responses to Nesf-1 in Nesf-1-responsive neurons (D) 
are shown. In C, numbers above each point indicate the number of neurons that 
responded to Nesf-1 over that responded to 55 mM KCl. In (D), values are 
normalized to those with 10-8 M Nesf-1 in each neuron and then averaged and 
expressed by means ± SEM (n = 18). *p < 0.01 by ANOVA.   
 
Figure 2. Nesfatin-1-induced [Ca2+] i  increases are inhibited under Ca2+-free 
conditions and by a blocker of N-type Ca2+ channels. 
A: Nesfatin-1 (Nesf-1) at 10-8 M failed to increase [Ca2+]i  under Ca2+-free 
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conditions made with 0.1 mM EGTA and no added Ca2+ in a single nodose 
ganglion neuron. Following the perfusate was switched to the control 
Ca2+-containing HKRB that elevated [Ca2+] i  in a transient manner, Nesf-1 
elicited an increase in [Ca2+] i . The neuron also responded to 55 mM KCl. B: 
Nesf-1 at 10-8 M failed to increase [Ca2+] i  in the presence of an N-type Ca2+ 
channel blocker ω-conotoxin GVIA (0.5 μM), but elicited an increase in [Ca2+] i  
after washing out the drug in a single nodose ganglion neuron that responded to 
55 mM KCl. The data are representative of 14 neurons in (A) and 9 in (B). C: The 
amplitude of [Ca2+] i  responses to 10-8 M Nesf-1 under control conditions, 
Ca2+-free conditions and those with ω-conotoxin. The amplitude of the response 
under test conditions is normalized to that to the second Nesf-1 administration 
under control conditions and expressed by percentage in each neuron, and then 
averaged for the neurons examined and expressed by means ± SEM. *p < 0.01 by 
unpaired t-test for Ca2+-free experiments. *p < 0.01 and **p < 0.05 by ANOVA 
for ω-conotoxin experiments.  
 
Figure 3. Incidence and distribution of nesfatin-1-, CCK-8- and CAP-responsive 
nodose ganglion neurons. 
A: A representative [Ca2+] i  recording of the nodose ganglion neurons that 
responded to nesfatin-1 (Nesf-1), CCK-8 and CAP (n = 33). B: Incidence of 
[Ca2+] i  responses to Nesf-1, CCK-8 and CAP in the neurons that responded to 55 
mM KCl, expressed by percentage. C: Overlap of the Nesf-1-, CCK-8- and 
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CAP-responsive nodose ganglion neurons. Incidences of specific subpopulations 
are; 16.0% for CAP-responsive, CCK-8- and Nesf-1-unresponsive neurons, 3.8% 
for CCK-8-responsive, CAP- and Nesf-1-unresponsive neurons, 33.8% for CAP- 
and CCK-8-responsive Nesf-1-unresponsive neurons, and 33.8% for neurons 
responsive to none of these agents. 
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